Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant TBEV Envelope protein E Protein, C-His

Catalog #:   EVV28902 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Mammalian cells
Accession: AEP20480.1
Protein length: Ser281-Gln684
Overview

Catalog No.

EVV28902

Expression system

Mammalian cells

Species

Tick-borne encephalitis virus (TBEV)

Protein length

Ser281-Gln684

Predicted molecular weight

47.10 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

AEP20480.1

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

polyprotein, Envelope protein E

Data Image
References

Peptides developed against receptor binding sites of the E glycoprotein neutralize tick-borne encephalitis virus., PMID:40181101

Antibodies against 12 infectious agents in free-ranging Eurasian beaver (Castor fiber L.) from the Czech Republic., PMID:40090533

Tick-borne encephalitis virus seroprevalence and infection incidence in Switzerland, 2020-2021., PMID:40069290

Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort., PMID:40019865

Remdesivir is active in vitro against tick-borne encephalitis virus and selects for resistance mutations in the viral RNA-dependent RNA polymerase., PMID:39973341

Prevalence and genetic diversity of tick-borne encephalitis virus in ixodid ticks from specific regions of northwestern Russia., PMID:39883660

Selection Pressure Profile Suggests Species Criteria among Tick-Borne Orthoflaviviruses., PMID:39459887

Phage Display Revealed the Complex Structure of the Epitope of the Monoclonal Antibody 10H10., PMID:39408641

Identification and characterization of new Siberian subtype of tick-borne encephalitis virus isolates revealed genetic variations of the Chinese strains., PMID:39179014

Poor virus-specific T-cell responses early after tick-borne encephalitis virus infection correlate with disease severity., PMID:39133062

Tick-borne encephalitis vaccine breakthrough infections induce aberrant T cell and antibody responses to non-structural proteins., PMID:39112523

Predicting immune response targets in orthoflaviviruses through sequence homology and computational analysis., PMID:39083139

The structure of immature tick-borne encephalitis virus supports the collapse model of flavivirus maturation., PMID:38959313

Comparison of Five Serological Methods for the Detection of West Nile Virus Antibodies., PMID:38793670

[Preparation of monoclonal antibodies against the envelope protein extracellular domain of Zika virus in mice]., PMID:38790101

Multiplex Serology for Sensitive and Specific Flavivirus IgG Detection: Addition of Envelope Protein Domain III to NS1 Increases Sensitivity for Tick-Borne Encephalitis Virus IgG Detection., PMID:38400061

Phylogenetic characterisation of tick-borne encephalitis virus from Lithuania., PMID:38324618

Results of Tick-Borne Encephalitis Virus (TBEV) Diagnostics in an Endemic Area in Southern Germany, 2007 to 2022., PMID:38140598

Structural diversity of tick-borne encephalitis virus particles in the inactivated vaccine based on strain Sofjin., PMID:38073510

Antiviral activity of porphyrins and porphyrin-like compounds against tick-borne encephalitis virus: Blockage of the viral entry/fusion machinery by photosensitization-mediated destruction of the viral envelope., PMID:38040199

Recombinant TBEV Protein E of the Siberian Subtype Is a Candidate Antigen in the ELISA Test System for Differential Diagnosis., PMID:37892100

Vaccination against tick-borne encephalitis elicits a detectable NS1 IgG antibody response., PMID:37838083

Rapid Generation of Recombinant Flaviviruses Using Circular Polymerase Extension Reaction., PMID:37515065

New Neutralizing Epitope Exposed on the Domain II of Tick-Borne Encephalitis Virus Envelope Glycoprotein E., PMID:37376556

Development of a novel virus-like particle-based vaccine for preventing tick-borne encephalitis virus infection., PMID:37328107

Horses as Sentinels for the Circulation of Flaviviruses in Eastern-Central Germany., PMID:37243194

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection., PMID:37153588

Charge-changing point mutations in the E protein of tick-borne encephalitis virus., PMID:36871232

Sterile 20-like kinase 3 promotes tick-borne encephalitis virus assembly by interacting with NS2A and prM and enhancing the NS2A-NS4A association., PMID:36840407

Identifying New Clusterons: Application of TBEV Analyzer 3.0., PMID:36838289

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial., PMID:36758067

Functional characterization and immunogenicity of a novel vaccine candidate against tick-borne encephalitis virus based on Leishmania-derived virus-like particles., PMID:36581050

Size Distribution of Inactivated Tick-Borne Encephalitis Virus Particles Revealed by a Comprehensive Physicochemical Approach., PMID:36289740

The interaction of viral fusion peptides with lipid membranes., PMID:36110043

The comparative genomic analysis provides insights into the phylogeny and virulence of tick-borne encephalitis virus vaccine strain Senzhang., PMID:36018897

Progressive Course of Chronic Tick-Borne Encephalitis Manifesting as Amyotrophic Lateral Sclerosis-like Syndrome 35 Years after the Acute Disease., PMID:36009082

Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses?, PMID:35887069

Signaling events evoked by domain III of envelop glycoprotein of tick-borne encephalitis virus and West Nile virus in human brain microvascular endothelial cells., PMID:35614140

Molecular Organisation of Tick-Borne Encephalitis Virus., PMID:35458522

Sensitisation and allergic reactions to alpha-1,3-galactose in Podlasie, Poland, an area endemic for tick-borne infections., PMID:35382677

Omsk hemorrhagic fever virus is a tick-borne encephalitis virus adapted to muskrat through host-jumping., PMID:35001393

Tick-borne encephalitis nonstructural protein NS1 expressed in E. coli retains immunological properties of the native protein., PMID:34920135

An Absolutely Conserved Tryptophan in the Stem of the Envelope Protein E of Flaviviruses Is Essential for the Formation of Stable Particles., PMID:34578308

Effect of immature tick-borne encephalitis virus particles on antiviral activity of 5-aminoisoxazole-3-carboxylic acid adamantylmethyl esters., PMID:34546870

[Biological properties and phylogenetic relationships of tick-borne encephalitis virus (Flaviviridae, Flavivirus) isolates of siberian subtype isolated in the south of East siberia in modern period]., PMID:34545723

Computational and Rational Design of Single-Chain Antibody against Tick-Borne Encephalitis Virus for Modifying Its Specificity., PMID:34452359

Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus., PMID:33857267

Phylogenetic analysis of tick-borne encephalitis virus strains found in an engorged tick and traveler returning from Russia., PMID:33571754

A high-throughput multiplex assay to characterize flavivirus-specific immunoglobulins., PMID:33022219

The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection., PMID:32988388

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant TBEV Envelope protein E Protein, C-His [EVV28902]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only